Laddar...
Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond
The blood–brain barrier permeant, copper-containing compound, Cu(II)(atsm), has successfully progressed from fundamental research outcomes in the laboratory through to phase 2/3 clinical assessment in patients with the highly aggressive and fatal neurodegenerative condition of amyotrophic lateral sc...
Sparad:
| I publikationen: | Life (Basel) |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694234/ https://ncbi.nlm.nih.gov/pubmed/33158182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life10110271 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|